{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-013357","form_type":"8-K","ticker":"CAPR","cik":"0001133869","company_name":"CAPRICOR THERAPEUTICS, INC.","filed_at":"2024-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.759781+00:00","generated_at":"2026-05-30T13:02:14.234961+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Capricor Therapeutics prices ~$75M public offering of 4.4M shares at $17/sh","bullets":["Gross proceeds ~$75M from 4,412,000 shares at $17.00/sh; underwriters have 30-day option for up to 661,800 additional shares.","Offering expected to close October 18, 2024; Piper Sandler and Oppenheimer act as joint book-running managers.","Net proceeds to fund continued product candidate development, manufacturing, working capital, and general corporate purposes.","Offering made under effective Form S-3 shelf registration; prospectus supplement filed October 16, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-013357","json":"https://secwatch.observer/filing/0001558370-24-013357.json","markdown":"https://secwatch.observer/filing/0001558370-24-013357.md","text":"https://secwatch.observer/filing/0001558370-24-013357.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133869/000155837024013357/0001558370-24-013357-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133869/000155837024013357/capr-20241016x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:02:14.234961+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}